(Q41444218)

30 September 2017

The Effect and Predictive Score of Gastric Bypass and Sleeve Gastrectomy on Type 2 Diabetes Mellitus Patients with BMI < 30 kg/m(2). (English)

1 reference

30 September 2017

0 references

1 reference

Wei-Jei Lee

1

1 reference

30 September 2017

Abdullah Almulaifi

2

1 reference

30 September 2017

Keong Chong

3

1 reference

30 September 2017

Shu-Chun Chen

4

1 reference

30 September 2017

Jun Juin Tsou

5

1 reference

30 September 2017

Kong-Han Ser

6

1 reference

30 September 2017

Yi-Chih Lee

7

1 reference

30 September 2017

Jung-Chien Chen

8

1 reference

30 September 2017

13 February 2015

1 reference

30 September 2017

1 reference

30 September 2017

25

1 reference

30 September 2017

1772-1778

1 reference

30 September 2017

10

1 reference

https://scigraph.springernature.com/pub.10.1007/s11695-015-1603-0

30 September 2017

0 references

cites work

IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1603-0

Diabetes in Asia: epidemiology, risk factors, and pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1603-0

The prevalence of meeting A1C, blood pressure, and LDL goals among people with diabetes, 1988-2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1603-0

Bariatric surgery: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1603-0

Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1603-0

Gastric bypass vs sleeve gastrectomy for type 2 diabetes mellitus: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1603-0

Bariatric surgery versus intensive medical therapy in obese patients with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1603-0

Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: the Diabetes Surgery Study randomized clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1603-0

Effect of laparoscopic Roux-en-Y gastric bypass surgery on type 2 diabetes mellitus with hypertension: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1603-0

Multidisciplinary diabetes care with and without bariatric surgery in overweight people: a randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1603-0

Diagnosis and Classification of Diabetes Mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1603-0

How do we define cure of diabetes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1603-0

Predicting the glycemic response to gastric bypass surgery in patients with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1603-0

Gastric bypass in Type 2 diabetes with BMI < 30: weight and weight loss have a major influence on outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1603-0

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1603-0

Laparoscopic Roux-en-Y versus mini-gastric bypass for the treatment of morbid obesity: a prospective randomized controlled clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1603-0

Experience in laparoscopic sleeve gastrectomy for morbidly obese Taiwanese: staple-line reinforcement is important for preventing leakage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1603-0

Metabolic surgery for non-obese type 2 diabetes: incretins, adipocytokines, and insulin secretion/resistance changes in a 1-year interventional clinical controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1603-0

Laparoscopic sleeve gastrectomy for diabetes treatment in nonmorbidly obese patients: efficacy and change of insulin secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1603-0

Effects of biliopanceratic diversion on type 2 diabetes in patients with BMI 25 to 35.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1603-0

Short-term outcomes of laparoscopic single anastomosis gastric bypass (LSAGB) for the treatment of type 2 diabetes in lower BMI (<30 kg/m(2)) patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1603-0

Beyond BMI: the need for new guidelines governing the use of bariatric and metabolic surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1603-0

Bariatric surgery: an IDF statement for obese Type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1603-0

Separate impact of obesity and glucose tolerance on the incretin effect in normal subjects and type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1603-0

Predictors of diabetes remission after bariatric surgery in Asia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1603-0

Type 2 diabetes after gastric bypass: remission in five models using HbA1c, fasting blood glucose, and medication status

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1603-0

Preoperative prediction of type 2 diabetes remission after Roux-en-Y gastric bypass surgery: a retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1603-0

Preoperative fasting plasma C-peptide level may help to predict diabetes outcome after gastric bypass surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1603-0

Low levels of C-peptide may not be a sign of pancreatic β-cell death or apoptosis: new insight into pancreatic endocrine function and indications for metabolic surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1603-0

Minireview: Hormonal and metabolic mechanisms of diabetes remission after gastrointestinal surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1603-0

Laparoscopic treatment of metabolic syndrome in patients with type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1603-0

Laparoscopic duodenal-jejunal exclusion in the treatment of type 2 diabetes mellitus in patients with BMI<30 kg/m2 (LBMI).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1603-0

Glycemic control after stomach-sparing duodenal-jejunal bypass surgery in diabetic patients with low body mass index.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1603-0

Outcome after gastrectomy in gastric cancer patients with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1603-0

Resolution of diabetes mellitus and metabolic syndrome in normal weight 24-29 BMI patients with One Anastomosis Gastric Bypass.

21 January 2018

1 reference

12 December 2020

Predicting success of metabolic surgery: age, body mass index, C-peptide, and duration score

1 reference

12 December 2020

C-peptide predicts the remission of type 2 diabetes after bariatric surgery

1 reference

12 December 2020

Bariatric surgery and prevention of type 2 diabetes in Swedish obese subjects

1 reference

12 December 2020

Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial

1 reference

12 December 2020

10.1007/S11695-015-1603-0

Identifiers

DOI

1 reference

Dimensions Publication ID

30 September 2017

0 references

1 reference